![outset medical ceo outset medical ceo](https://media.bizj.us/view/img/11598110/outset-medical-ceo-leslie-trigg*800xx3500-1969-0-184.jpg)
The cookie is used to store the user consent for the cookies in the category "Performance". san jose, calif.- ( business wire )-outset medical, inc. This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". The cookie is used to store the user consent for the cookies in the category "Other. This cookie is set by GDPR Cookie Consent plugin. Outset Medical CEO has no regrets about IPO pricing after stock jumps 125 in debut Enlarge Outset Medical CEO Leslie Trigg did a virtual bell-ringing to open Nasdaq trading on Tuesday, when her. Leslie received her undergraduate degree from Northwestern. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". Leslie has served as our Chief Executive Officer since November 2014 and was elected Chair in 2022. The cookie is used to store the user consent for the cookies in the category "Analytics". These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly. from The Haas School of Business, UC Berkeley.
![outset medical ceo outset medical ceo](https://www.outsetmedical.com/wp-content/uploads/Steve-Williamson-Outset-Medical-e1610642240898-scaled-240.jpg)
degree from Northwestern University and an M.B.A. Trigg serves on the board of directors of Adaptive Biotechnologies (NASDAQ: ADPT) and on the board of directors of the Medical Device Manufacturers Association. She also previously held positions with FoxHollow Technologies (acquired by ev3/Covidien), a manufacturer of devices to treat peripheral artery disease, Cytyc, a diagnostic and medical device company, Pro-Duct Health (acquired by Cytyc), a medical device company, and Guidant, a cardiovascular medical device company. Prior to that, she served in several roles at Lutonix (acquired by CR Bard), a medical device company, from January 2010 to February 2012, most recently as Executive Vice President, and as Chief Business Officer of AccessClosure (acquired by Cardinal Health), a medical device company, from September 2006 to June 2009. She joined the Company from Warburg Pincus, a private equity firm, where she was an Executive in Residence from March 2012 to March 2014. Leslie has served as our Chief Executive Officer since November 2014 and was elected Chair in 2022.